Evelo Biosciences, Inc.
EVLO · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$114,527 | -$122,176 | -$93,666 | -$85,472 |
| Dep. & Amort. | $2,060 | $2,216 | $2,026 | $1,764 |
| Deferred Tax | $0 | $3,219 | -$6 | -$166 |
| Stock-Based Comp. | $15,158 | $15,846 | $8,468 | $8,165 |
| Change in WC | -$9,666 | $2,068 | $7,765 | $3,474 |
| Other Non-Cash | $5,740 | $2,102 | $2,350 | $255 |
| Operating Cash Flow | -$101,235 | -$96,725 | -$73,063 | -$71,980 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$622 | -$1,519 | -$1,321 | -$3,032 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $55,000 |
| Other Inv. Act. | $0 | $38 | $6 | $2 |
| Investing Cash Flow | -$622 | -$1,481 | -$1,315 | $51,970 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,123 | $14,778 | $10,000 | $4,481 |
| Stock Issued | $84,544 | $81,751 | $54,994 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $234 | $1,011 | $471 | $511 |
| Financing Cash Flow | $81,655 | $97,540 | $65,465 | $4,992 |
| Forex Effect | -$454 | $0 | $0 | $0 |
| Net Chg. in Cash | -$20,656 | -$666 | -$8,913 | -$15,018 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $69,754 | $70,420 | $79,333 | $94,351 |
| End Cash | $49,098 | $69,754 | $70,420 | $79,333 |
| Free Cash Flow | -$101,857 | -$98,244 | -$74,384 | -$75,012 |